vTv Therapeutics VTVT
NASDAQ VTVT
$30.57 -1.28 (-4.02%)
At close: Oct 2, 2026 · 4:00 PM EDT

vTv Therapeutics (VTVT) Return on Invested Capital [ROIC] (2024)

Updated

vTv Therapeutics' Return on Invested Capital [ROIC] came in at -150.12% for Q4 2024, down 24.98 percentage points from the prior quarter.

Analysis

vTv Therapeutics (VTVT) Return on Invested Capital [ROIC] (2024) Analysis & Trends

Going back to Q1 2024, vTv Therapeutics' Return on Invested Capital [ROIC] data covers 4 quarters.

  • The five-year range for quarterly Return on Invested Capital [ROIC] is -3164.49% (Q1 2024) to -98.47% (Q2 2024).
  • Business Quant data shows VTVT's Return on Invested Capital [ROIC] at -125.14% (Q3 2024), -98.47% (Q2 2024) and -3164.49% (Q1 2024) in the three quarters before Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 16.10%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 18.68%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 3.56%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 21.95%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 28.83%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 14.33%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 13.44%
10 vTv Therapeutics 379.35 Mn 379.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -150.12%
Sep 30, 2024 -125.14%
Jun 30, 2024 -98.47%
Mar 31, 2024 -3,164.49%
API Access

vTv Therapeutics Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=VTVT&period=max&api_key=YOUR_API_KEY